Pharmaceutical Segment in Mass Spectrometry Market to Grow in Double Digit in Coming Years

The global market is increasing, due to increasing food safety concern, growing demand in life science and clinical analysis sector, and increasing healthcare expenditure and development of healthcare infrastructure.  In addition, the technological advancements with advent of mass spectrometry equipment are further encouraging the growth of the market.




Based on platform, the hybrid mass spectrometry segment accounted for the largest share during the forecast period. Among the various end-users, the pharmaceutical segment accounted for the largest share in the global market in 2015; and the segment is expected to grow at 8.8% CAGR during 2016 – 2022.



In addition, the increasing food safety concerns to prevent the food from spoilage also acts as a major growth driver in the global mass spectrometry market. In order to maintain the safety and quality of food, the presence of required microorganisms needs to be confirmed, and the presence of microorganisms which may lead to spoilage must be detected. Both government authorities and food companies use microbiological analysis to monitor contamination and analyze its trends to detect emerging risks.


The key companies operating in the global mass spectrometry market include Danaher Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies Inc., Waters Corporation, PerkinElmer Inc., LECO Corporation, Dani Instruments S.p.A, Protea Biosciences Group Inc., Microsaic Systems PLC, Endress+Hauser Inc., Jeol USA Inc., and Elico Ltd.

Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com


Connect with us: LinkedIn | Twitter | Google + | Facebook

Comments

Popular posts from this blog

Hospital Bed Market by Type, Treatment, Geography – Market Size, Growth and Demand

How the Patient Handling Equipment Market Has Witnessed Substantial Growth in Coming Years?

Facial Skin Ablative Treatment Market To Reach $8,394.3 Million by 2030